J Trauma Acute Care Surg: Chronic safety assessment of hemostatic self-expanding foam: 90-day survival study and intramuscular biocompatibility

Rago A, Duggan MJ, Hannett P, Brennecke LH, LaRochelle A, Khatri C, Zugate GT, Chang Y, SharmaU, King DR. Chronic safety assessment of hemostatic self-expanding foam: 90-day survival study and intramuscular biocompatibility.

Summary: Noncompressible hemorrhage is a significant cause of preventable death in trauma, with no effective presurgical treatments. We previously described the efficacy and 28-day safety of a self-expanding hemostatic foam in swine models. We hypothesized that the 28-day results would be confirmed at a second site and that results would be consistent over 90 days. Finally, we hypothesized that the foam material would be biocompatible following intramuscular implantation.

J Trauma Acute Care Surg. 2015 Oct;79(4 Suppl 2):S78-84

 

October 1, 2015